News, Feeds, and Subscriptions

Use this page to stay up-to-date with industry and employer news and trends. When you subscribe to a feed updates are delivered directly to your favorite news reader, inbox, mobile device and/or smart phone.

Search Industry News

Use Reeve Recruiting's custom search engine to query the latest biopharma, biotech, and medical device news from leading industry publications and news sites. Start searching here.

  Industry News | Subscribe  

The investors claim that the pharmaceutical company's board knew that Abstral's sales were being driven by Drs. Xiulu Ruan and John Patri...
Posted: August 22, 2018, 12:33 am
Kane Biotech Inc. is a biotechnology company engaged in the research, development and commercialization of technologies and products that...
Posted: August 21, 2018, 9:33 pm
Nature's Best Brands, Inc. announces acquisition of Unisource Health, Inc. ... The RM-3A medical device is a powerful tool used by physic...
Posted: August 21, 2018, 9:22 pm
The ERP5 of CTI BioPharma Corp. (NasdaqCM:CTIC) is 15397. The lower the ERP5 rank, the more undervalued a company is thought to be.
Posted: August 21, 2018, 8:42 pm
The ERP5 of Arbutus Biopharma Corporation (NasdaqGS:ABUS) is 15316. The lower the ERP5 rank, the more undervalued a company is thought to...
Posted: August 21, 2018, 8:37 pm

Viewing page 1 of 13|Next Page

  Company News | Subscribe  

Novo Nordisk obtains positive phase 3a results for a late-stage study in patients with Type 2 diabetes with moderate renal impairment. Th...
Posted: August 21, 2018, 11:37 pm
AstraZeneca (LON:AZN)'s stock had its “buy” rating reiterated by analysts at Deutsche Bank in a research report issued on Friday, July 27...
Posted: August 21, 2018, 11:37 pm
AstraZeneca (LON:AZN) received a GBX 6,500 ($83.09) price target from analysts at Barclays in a research report issued on Friday, July 27th.
Posted: August 21, 2018, 11:37 pm
AbbVie Inc (NYSE:ABBV) EVP Michael Severino sold 50,000 shares of the company's stock in a transaction dated Friday, August 17th. The sha...
Posted: August 21, 2018, 11:15 pm
AstraZeneca (NYSE:AZN) was upgraded by analysts at ValuEngine from a “hold” rating to a “buy” rating in a research note issued to investo...
Posted: August 21, 2018, 11:03 pm

Viewing page 1 of 75|Next Page

  Industry Tweets | Subscribe  

Viewing page 1 of 65|Next Page